Limitations, agreements, and source contact

Bendamustine, Wkly Bortezomib, Lenalidomide and Dexamethasone for Multiple Myeloma · Source last updated 2018-07-10

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

limitations And Caveats

description

The trial terminated in June 2014 when Celgene could no longer supply lenalidomide for the study

point Of Contact

email

ssmith8@lumc.edu

organization

Loyola University Medical Center

phone

708-327-3142

title

Scott Smith, M.D., Ph.D.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice